Apollomics, Inc.

APLMW Stock Healthcare Biotechnology
$0.01
+0.00 (+1.98%)
Price as of Oct 15, 2026 market close

Performance

1 Month
-11.2%
3 Months
-47.2%
YTD
-7.2%
1 Year
-46.1%
3 Year annualized
-41.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
239.1%
Largest decline max drawdown, since Nov 2021
-98.8%
Risk-adjusted return Sharpe ratio, 1-year
0.71

Own APLMW?

See how APLMW contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.